Vantara & Rao
Client: HelixGen Biosciences
HelixGen needed to license a novel biologic to an overseas pharmaceutical partner while navigating Indian drug regulatory approvals and clinical trial data-sharing restrictions.
Our life sciences team structured the licensing agreement alongside a regulatory strategy that satisfied CDSCO requirements and protected HelixGen's underlying IP throughout the transfer.
The licensing agreement closed with full regulatory clearance and royalty terms favorable to HelixGen.
HelixGen secured recurring licensing revenue and validated its Genome Valley research pipeline for further international partnerships.
Schedule a consultation to discuss how our pharmaceuticals & life sciences practice can help.
Schedule Consultation